Regina Groves

Regina Groves

Director/Board Member at ATRICURE, INC.

Net worth: 2 M $ as of 30/05/2026

67 year
Health Technology
Consumer Services
Process Industries

Profile

Regina E.
Groves
is currently an Independent Director at AtriCure, Inc. since 2017, an Independent Director at Fulgent Genetics, Inc. since 2023, a Director at Stimwave Technologies, Inc., and a Director at Advanced Nanotherapies, Inc. since 2020.
Former roles include Chief Executive Officer & Director at REVA Medical, Inc. from 2017 to 2019, Chairman at Foxcroft School from 2010 to 2016, Director at Stimwave LLC from 2020 to 2022, Vice President-Quality & Regulatory CRDM at Medtronic, Inc. from 2006 to 2008, and Vice President & General Manager at AF Solutions Holdings LLC.
Education includes undergraduate studies at the University of Florida and an MBA from Harvard Graduate School of Education.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/05/2026 39,859 ( 0.08% ) 1 M $ 30/05/2026
13/05/2026 28,099 ( 0.09% ) 509 716 $ 30/05/2026

Regina Groves active positions

CompaniesPositionStart
ATRICURE, INC. Director/Board Member 20/03/2017
FULGENT GENETICS, INC. Director/Board Member 02/01/2023
Director/Board Member -
Director/Board Member 31/08/2020

Former positions of Regina Groves

CompaniesPositionEnd
Director of Finance/CFO 30/11/2020
REVA MEDICAL INC Chief Executive Officer 24/03/2019
Chairman 31/12/2015
Corporate Officer/Principal 31/12/2007
Corporate Officer/Principal -
See the detail of Regina Groves's experience

Training of Regina Groves

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Process Industries

Health Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!